140 related articles for article (PubMed ID: 26977025)
21. Expression of the prolyl isomerase Pin1 is a useful indicator of sensitivity to chemoradiotherapy in advanced esophageal squamous cell carcinoma.
Fukuchi M; Fukai Y; Sohda M; Miyazaki T; Nakajima M; Inose T; Tanaka N; Tsukada K; Kato H; Kuwano H
Oncol Rep; 2009 Apr; 21(4):853-9. PubMed ID: 19287979
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients.
Fujimoto Y; Nakanishi Y; Yoshimura K; Shimoda T
Gastric Cancer; 2003; 6(1):39-48. PubMed ID: 12673425
[TBL] [Abstract][Full Text] [Related]
23. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
[TBL] [Abstract][Full Text] [Related]
24. The usefulness of preoperative 18FDG positron-emission tomography and computed tomography for predicting the malignant potential of gastrointestinal stromal tumors.
Tokumoto N; Tanabe K; Misumi T; Fujikuni N; Suzuki T; Ohdan H
Dig Surg; 2014; 31(2):79-86. PubMed ID: 24776690
[TBL] [Abstract][Full Text] [Related]
25. Immunostaining of phospho-histone H3 and Ki-67 improves reproducibility of recurrence risk assessment of gastrointestinal stromal tumors.
Uguen A; Conq G; Doucet L; Talagas M; Costa S; De Braekeleer M; Marcorelles P
Virchows Arch; 2015 Jul; 467(1):47-54. PubMed ID: 25823616
[TBL] [Abstract][Full Text] [Related]
26. Promoting role of cholecystokinin 2 receptor (CCK2R) in gastrointestinal stromal tumour pathogenesis.
Quattrone A; Dewaele B; Wozniak A; Bauters M; Vanspauwen V; Floris G; Schöffski P; Chibon F; Coindre JM; Sciot R; Debiec-Rychter M
J Pathol; 2012 Dec; 228(4):565-74. PubMed ID: 22786615
[TBL] [Abstract][Full Text] [Related]
27. Ki67 as a prognostic factor for long-term outcome following surgery in gastrointestinal stromal tumors.
Turkel Kucukmetin N; Cicek B; Saruc M; Ersoy O; Vardareli E; Onder O; Gurluler E; Tiftikci A; Goksel S; Tozun N
Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1276-80. PubMed ID: 26275084
[TBL] [Abstract][Full Text] [Related]
28. Pin1 is related with clinical stage of papillary thyroid carcinoma.
Jiang L; Chu H; Zheng H
World J Surg Oncol; 2016 Mar; 14():95. PubMed ID: 27029791
[TBL] [Abstract][Full Text] [Related]
29. Expression and significance of Pin1 mRNA in circulating mononuclear cells from non-small cell lung cancer patients during perioperative period.
Ai ZH; Zhang WX; Luo WJ; Huang LJ; Pan Y
Ai Zheng; 2009 Mar; 28(3):268-73. PubMed ID: 19619441
[TBL] [Abstract][Full Text] [Related]
30. Pin1 is overexpressed and correlates with poor prognosis in gastric cancer.
Shi M; Chen L; Ji J; Cai Q; Yu Y; Liu B; Zhu Z; Zhang J
Cell Biochem Biophys; 2015 Mar; 71(2):857-64. PubMed ID: 25280783
[TBL] [Abstract][Full Text] [Related]
31. Ki-67 labeling index may be a promising indicator to identify "very high-risk" gastrointestinal stromal tumor: a multicenter retrospective study of 1022 patients.
Liu X; Qiu H; Zhang P; Feng X; Chen T; Li Y; Tao K; Li G; Sun X; Zhou Z;
Hum Pathol; 2018 Apr; 74():17-24. PubMed ID: 28962945
[TBL] [Abstract][Full Text] [Related]
32. Gastrointestinal stromal tumors: usefulness of immunohistochemistry, flow cytometry and fluorescence in situ hybridization.
Fontana MG; Rossi E; Bassotti G; Aquilano MC; Cadei M; Grigolato P; Villanacci V
J Gastroenterol Hepatol; 2007 Nov; 22(11):1754-9. PubMed ID: 17914946
[TBL] [Abstract][Full Text] [Related]
33. Prognostic assessment of gastrointestinal stromal tumor.
Yan H; Marchettini P; Acherman YI; Gething SA; Brun E; Sugarbaker PH
Am J Clin Oncol; 2003 Jun; 26(3):221-8. PubMed ID: 12796588
[TBL] [Abstract][Full Text] [Related]
34. Significant correlation of peptidyl-prolyl isomerase overexpression in Merkel cell carcinoma with overall survival of patients.
Lill C; Schneider S; Pammer J; Loewe R; Gedlicka W; Houben R; Heiduschka G; Brunner M; Thurnher D
Head Neck; 2011 Sep; 33(9):1294-300. PubMed ID: 21837699
[TBL] [Abstract][Full Text] [Related]
35. [Study on associated biomarkers influencing recurrence, metastasis and prognosis in patients with gastrointestinal stromal tumors after complete resection].
Fang YJ; Zhang RX; Luo RZ; Ou QJ; Wan DS; Pan ZZ; Wu XJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):242-6. PubMed ID: 23536344
[TBL] [Abstract][Full Text] [Related]
36. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.
Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE
Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047
[TBL] [Abstract][Full Text] [Related]
37. Gastrointestinal stromal tumors - a clinical-morphological study on 15 cases.
Pleşea IE; Chiuţu L; Bordu SI; Georgescu I; Georgescu EF; Ciobanu D; Mărgăritescu ND; Comănescu V; Nemeş R
Rom J Morphol Embryol; 2014; 55(2 Suppl):513-23. PubMed ID: 25178321
[TBL] [Abstract][Full Text] [Related]
38. [Prognostic significance of clinicopathologic parameters in gastrointestinal stromal tumor: a study of 156 cases].
Liang YM; Li XH; Lü YY; Lü YL; Zhong M; Pu XL; Li WM
Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):233-8. PubMed ID: 17706113
[TBL] [Abstract][Full Text] [Related]
39. [Clinical analysis of prognostic factors for patients with gastrointestinal stromal tumors].
Jie ZG; Xie XP; Qin KW; Liu Y; Li ZR; Dai AB; Yao YX
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):210-2. PubMed ID: 16167229
[TBL] [Abstract][Full Text] [Related]
40. [Morphological characteristics and prognostic criteria for gastrointestinal stromal tumors].
Tsyganova IV; Anurova OA; Mazurenko NN
Arkh Patol; 2011; 73(6):37-42. PubMed ID: 22379899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
